Results: Thus, the concentration of MMP-9 in the serum of patients with heart failure I, II and III class was increased as compared with the control subjects and averaged 4.51 ± 0.27 ng/ml. The concentration of TIMP-4 in the serum of patients with heart failure I, II and III class was reduced as compared with the control subjects and averaged 0.26 ± 0.04 ng/ml. Concentration in blood of MMP-9 for patients with class II heart failure was 12% higher than the class I, and class III at -24% higher than on class II heart failure. The concentration of TIMP-4 in patients with class II was 14% lower than the class I, and class III at -25% lower than class II heart failure.
